Metraipolis › archive › dc_0055f2c19447

Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth — Europe PMC PMID:42032367

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42032367
DOI
10.1038/s41388-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-03T06:25:15.791Z
SHA-256 of the archived text
61711392b4ceeec6aed987d5a984112badb49a2aaa117e1faff2a81d556bb675
Stable URL of this page
https://metraipolis.com/documento/dc_0055f2c19447

How to cite

Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth — Europe PMC PMID:42032367 — Europe PMC (en), https://europepmc.org/article/MED/42032367 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0055f2c19447 (Metraipolis archive dc_0055f2c19447, sha256 61711392b4ceeec6aed987d5a984112badb49a2aaa117e1faff2a81d556bb675)
BibTeX
@misc{dc0055f2c19447,
  title = {Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth — Europe PMC PMID:42032367},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42032367},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0055f2c19447; sha256 61711392b4ceeec6aed987d5a984112badb49a2aaa117e1faff2a81d556bb675},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42032367. Agents can read the archived copy with the MCP tool read_document.